Cho M, Cummings R D
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma Center for Molecular Medicine, Oklahoma City 73190, USA.
Biochemistry. 1996 Oct 8;35(40):13081-8. doi: 10.1021/bi961181d.
Galectin-1 is a beta-galactoside-binding protein secreted by animal cells, and it exists in a monomer-dimer equilibrium (Kd approximately 7 microM). The function(s) of galectin-1 is(are) not yet defined, but dimerization and divalency are presumably important. Crystal structures of the mammalian galectin-1 dimer predict N- and C-terminal interactions at the subunit interface. To examine the mechanism of dimer formation and possibly generate active monomeric galectin-I, mutations were made in the N- and C-termini of recombinant hamster galectin-1. N-Gal-1 contains disruptions of three hydrophobic amino acids at the N-terminus; V5D-Gal-1 contains a single mutation of Val5 to Asp; N/C-Gal-1 contains multiple changes in hydrophobic amino acids at both the N- and C-termini. All mutants behave as monomers in size-exclusion HPLC and native gel electrophoresis. N-Gal-1 and V5D-Gal-1 bind weakly to lactosyl-Sepharose, but N/C-Gal-1 is nonfunctional. In equilibrium dialysis, N-Gal-1 and V5D-Gal-1 bind N-acetyllactosamine with a Kd approximately 90 microM, which is similar to that of native lectin. At high concentrations, V5D-Gal-1 and N-Gal-1 dimerize and can be covalently cross-linked with disuccinimidyl suberate. The Kd values of the monomer-dimer equilibrium for V5D-Gal-1 and N-Gal-1 are estimated to be approximately 60 microM and approximately 250 microM, respectively. The cross-linked dimers of V5D and N-Gal-1 were isolated and were similar to native lectin in both hemagglutinating activity and high-affinity binding to lactosyl-Sepharose. Thus, specific mutations in galectin-1 can alter monomer-dimer equilibrium without affecting carbohydrate-binding activity. The availability of active monomers and functional covalent dimers of galectin-1 should aid in future studies aimed at understanding the biological function(s) of the lectin and the role of divalency.
半乳糖凝集素-1是一种由动物细胞分泌的β-半乳糖苷结合蛋白,它以单体-二聚体平衡状态存在(解离常数约为7微摩尔)。半乳糖凝集素-1的功能尚未明确,但二聚化和双价性可能很重要。哺乳动物半乳糖凝集素-1二聚体的晶体结构预测了亚基界面处的N端和C端相互作用。为了研究二聚体形成的机制并可能产生活性单体半乳糖凝集素-I,对重组仓鼠半乳糖凝集素-1的N端和C端进行了突变。N-Gal-1在N端有三个疏水氨基酸的破坏;V5D-Gal-1包含Val5到Asp的单个突变;N/C-Gal-1在N端和C端的疏水氨基酸都有多处变化。所有突变体在尺寸排阻高效液相色谱和天然凝胶电泳中均表现为单体。N-Gal-1和V5D-Gal-1与乳糖基琼脂糖的结合较弱,但N/C-Gal-1无功能。在平衡透析中,N-Gal-1和V5D-Gal-1与N-乙酰乳糖胺结合,解离常数约为90微摩尔,与天然凝集素相似。在高浓度下,V5D-Gal-1和N-Gal-1会二聚化,并可以用辛二酸二琥珀酰亚胺酯进行共价交联。V5D-Gal-1和N-Gal-1单体-二聚体平衡的解离常数估计分别约为60微摩尔和约250微摩尔。V5D和N-Gal-1的交联二聚体被分离出来,其血凝活性和与乳糖基琼脂糖的高亲和力结合与天然凝集素相似。因此,半乳糖凝集素-1中的特定突变可以改变单体-二聚体平衡而不影响碳水化合物结合活性。半乳糖凝集素-1活性单体和功能性共价二聚体的可得性将有助于未来旨在了解凝集素生物学功能和双价性作用的研究。